CG Oncology CGON Non Cash Lease Expense
Non Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept ck0001991792:NonCashLeaseExpense.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's non cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's non cash lease expense?
- CG Oncology (CGON) reported non cash lease expense of $13K in Q1 2026.
- How has CG Oncology's non cash lease expense changed year-over-year?
- CG Oncology's non cash lease expense increased by 192.9% year-over-year, from -$14K to $13K.
- What does non cash lease expense mean?
- This represents the portion of lease expenses that does not involve a cash outflow, typically associated with the amortization of right-of-use assets under lease accounting standards. It provides visibility into the underlying cost of leased facilities or equipment without the cash flow impact. This is essential for evaluating the true operational cost structure of the business.